mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.005 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.15 |
0.005 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.006 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.006 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.007 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.007 |